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http://www.rbej.com/content/10/1/37RESEARCH Open AccessPhosphorylation of h1 Calponin by PKC epsilon
may contribute to facilitate the contraction of
uterine myometrium in mice during pregnancy
and labor
Lesai Li1†, Yong Zhang2,3† and Changju Zhou1*Abstract
Background: The timely onset of powerful uterine contractions during parturition occurs through thick and thin
filament interactions, similar to other smooth muscle tissues. Calponin is one of the thin filament proteins.
Phosphorylation of calponin induced by PKC-epsilon can promote the contraction of vascular smooth muscle.
While the mechanism by which calponin regulates the contraction of pregnant myometrium has rarely been
explored. Here, we explore whether PKC-epsilon/h1 calponin pathway contribute to regulation of myometrial
contractility and development of parturition.
Methods: We detected the expression of h1 calponin, phosphorylated h1 calponin, PKC-epsilon and
phosphorylated PKC-epsilon in the different stages of mice during pregnancy and in labor by the method of
western blot and recorded the contraction activity of myometrium strips at the 19th day during pregnancy with
different treatments by the organ bath experiments.
Results: The level of the four proteins including h1 calponin, phosphorylated h1 calponin, PKC-epsilon and
phosphorylated PKC-epsilon was significantly increased in pregnant mice myometrium as compared with that
in nonpregnant mice. The ratios of phosphorylated h1 calponin/h1 calponin and phosphorylated PKC-epsilon/
PKC-epsilon were reached the peak after the onset of labor in myometrium in the mice. After the treatment
of more than 10(9-) mol/L Psi-RACK (PKC-epsilon activator), the contractility of myometrium strips from mice
was reinforced and the level of phosphorylated h1 calponin increased at the same time which could be
interrupted by the specific inhibitor of PKC-epsilon. Meanwhile, the change of the ratio of phosphorylated h1
calponin/h1 calponin was consistent with that of contraction force of mice myometrium strips.
Conclusions: These data suggest that in mice myometrium, phosphorylation of h1 calponin induced by the
PKC-epsilon might facilitate the contraction of uterine in labor and regulate pregnant myometrial contractility.
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Labor may occur due to a loss of myometrial quiescence
or an active increase in uterine contractility, or a com-
bination of both. Several contractile-associated proteins
have been proposed to contribute to reversal of quies-
cence and promote contraction of the uterus during* Correspondence: frogno@126.com
†Equal contributors
1Department of Obstetrics and Gynecology, the third Xiangya Hospital,
Central South University, Changsha 410013, China
Full list of author information is available at the end of the article
© 2012 Li et al.; licensee BioMed Central Ltd. T
Commons Attribution License (http://creativec
reproduction in any medium, provided the orlabor [1,2]. Calponin is one of the thin filament proteins
and a critical component of smooth muscle contractile
machinery [3], while the mechanism by which calponin
regulates the contraction of pregnant myometrium has
rarely been explored. Calponin (CaP) was first isolated
in smooth muscle over 20 years ago as a potential thin
filament regulatory protein [4]. So far, Calponin is now
known as a family of homologous actin filament-asso-
ciated proteins expressed in both smooth muscle and
non-muscle cells. Three isoforms of calponin have been
found in the vertebrates as the products of threehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Li et al. Reproductive Biology and Endocrinology 2012, 10:37 Page 2 of 8
http://www.rbej.com/content/10/1/37homologous genes: a basic calponin (smooth muscle-
specific basic CaP, h1-calponin, h1 CaP) [5], a neutral
calponin (h2-calponin) [6] and an acidic Calponin (h3
calponin) [7].
A series of animal experiments have been conducted
about the role of calponin in smooth muscle contrac-
tion, the findings show the h1 calponin is specific to dif-
ferentiated smooth muscle cells and up-regulated during
post-natal development [8], which consistent with a role
in contractile function. Calponin inhibits the contraction
of smooth muscle through its interacting with actin and
Calmodulin and inhibiting action-activated myosin
ATPase activity without affecting myosin light chain
(LC20) phosphorylation [9], but the phosphorylation of
calponin induced by PKC, in particular PKC-ε displays a
dramatic reduction in affinity for actin and is unable to
inhibit myosin ATPase activity which promotes the con-
traction of smooth muscle. Phosphorylation of calponin
by PKC-ε results in contraction of porcine coronary ar-
tery [10] whereas unphosphorylated calponin relaxes
single permeabilized vascular smooth cells pre-
contracted with phenylephrine and PKC-ε [11]. Previ-
ously, Winder [4] found Calponin was a substrate for
PKC in 1990, followed by the discovery by Horowitz
[11] that calponin is a substrate for PKC-ε. Whereafter,
Menice [12] found that PKC-ε and h1 calponin co-
immunoprecipitate and co-translocate to the vicinity of
the plasmalemma in ferret vascular smooth muscle and
that PKC-ε directly binds to h1 calponin in vitro [13].
The subcellular localization of calponin is also affected
by PKC-dependent phosphorylation. Moreover, depho-
sphorylation of calponin by a type 2A protein phosphat-
ase restores actin binding and inhibition of myosin
ATPase [14]. In general, it has been postulated that
agonist-induced, Ca2 + -independent contraction of
smooth muscle is mediated by PKC-ε through its ability
to phosphorylate calponin.
Although the function of h1 calponin in smooth
muscle contraction has been extensively investigated, the
physiological function of calponin in uterine myome-
trium is still inconclusive because relatively few studies
have been performed in pregnant myometrium regard-
ing the possible function of h1 calponin and PKC-ε.
However, the information established from vascular
smooth muscle studies laid a foundation for investiga-
tions on the function of h1 calponin in uterine myome-
trium. An increased protein level of h1 calponin in term
pregnant human myometrium has been reported [15],
but the mechanism by which h1 calponin regulates myo-
metrium contraction has not been explored. Then, a
new idea was presented whether the contraction of ges-
tational myometrial was regulated by the PKC-ε/ h1 cal-
ponin signaling. Whether the inhibition of h1 calponin
on actin may be reversed by PKC-ε-dependentphosphorylation in a gestation-related manner has not
been explored. The purpose of the present study was to
determine if the activation of PKC-ε and phosphoryl-
ation of h1 calponin might correlate with the onset of
labor and whether phosphorylation of h1 calponin
induced by PKC-ε regulates pregnant myometrial con-
tractility in mice.
Methods
Animals and tissue handling
All procedures were approved by our institutional ani-
mal care and use committee. 8-week-old female BALB/C
mice were randomly divided into seven groups (10 mice
per group): nonpregnant(NP), pregnant D7(the 7th day
during pregnancy), pregnant D12(the 12th day during
pregnancy), pregnant D17(the 17th day during preg-
nancy), pregnant D18(the 18th day during pregnancy),
pregnant D19(the 19th day during pregnancy), in labor
(IL, after the first pup was delivered). Mice were killed
by cervical dislocation. Uterine horns were excised and
opened up along the mid-line. In pregnant mice, the pla-
centae and fetuses were removed and pups decapitated.
Longitudinal strips of myometrium were isolated from
the tissue and freed of any endometrium, under a dis-
secting microscope, and cleaned of any blood by rinsing
in Krebs solution (154 mM NaCl, 5.4 mM KCl, 1.2 mM
MgSO4, 1.6 mM CaCl2, 5.5 mM glucose, and oxyge-
nated with 95% O2-5% CO2, producing a pH of 7.4).
The strips were snap frozen in liquid N2 until use, or
prepared immediately for contractile studies.
Western blot analysis
Muscles were stored in liquid N2 until processed as pre-
viously described for protein extraction for Western
blotting [16]. The concentration of extracted proteins
was determined by the Bradford Protein Assay kit (Santa
Cruz, USA) according to the manufacturer’s instructions.
Samples were subjected to electrophoresis on 10% SDS
polyacrylamide gels. Gels were sealed with a blotting
membrane. Membranes were placed into blocking buffer
containing 5% non-fat milk and incubated for 2 hours at
room temperature on a rocking platform. Primary anti-
body was added to each lane and incubated for 2 h, fol-
lowed by three 10 min washes with TBST. Secondary
antibody (1:10,000, Santa Cruz, USA) was then added to
each lane and incubated for 1h, and the blot was sub-
jected to three 10 min washes in TBST. Immunoreactiv-
ity was visualized by enhanced chemiluminescence (ECL
Pierce Company, USA), images were captured on X-ray
film (Kodak, American), and protein quantification was
determined by using Gel Pro Analyzer 4 image analysis
software (Media Cybernetics, USA). The h1 calponin
antibody (1:3000, Millipore, USA) detected total h1 cal-
ponin protein levels. The phospho-h1 calponin antibody
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for the PKC (Protein kinase C) phosphorylation site at
Ser175. The PKC-ε antibody (1:1000, Millipore, USA)
was used to detect total PKC-ε protein levels. The phos-
pho- PKC-ε antibody (1:1000, Santa Cruz, USA) used in
this study detected phosphorylated PKC-ε which was
catalytically activated by phosphorylation at Ser729.
Contractile studies
Strips of myometrium (7 ~ 8 mm length × 2 ~ 3mm
wide) were dissected from mice uterine at the time of
Day 19 in pregnancy, tied at each end with silk thread
and mounted vertically in 30-ml tissue baths. One tissue
end was tied to a fixed hook, the other to an isometric
tension transducer (Chengdu Instruments, China) and
equilibrated in Krebs solution (154 mM NaCl, 5.4 mM
KCl, 1.2 mM MgSO4, 1.6 mM CaCl2, 5.5 mM glucose,
and oxygenated with 95% O2-5% CO2, producing a pH
of 7.4). Experiments were performed at 37°C as previ-
ously described [17]. Preparations were allowed to
equilibrate for 1 h before initiation of experiments. All
myometrial strips were stretched to the optimal length,
defined as the length corresponding to maximal force
development with regard to spontaneous contraction
[18]. The bath buffer solution was changed every 15
minutes during equilibration. The contractile activity
was digitalized with BL-420E + biological and functional
experimental system (Chengdu Technology & Market
Co, LTD, China). To investigate the role of PKC-ε/ h1
calponin pathway to contractile activation, myometrial
strips isolated from mice at the 19th day during preg-
nancy were stimulated with the PKC-ε specific activator
(Psi-RACK, Anaspec, American), with the concentration
ranging from 10-12 mol/L to 10-6 mol/L. The control
group underwent a Psi-RACK concentration of 0 mol/L.
To further investigate whether PKC-ε was involved in
the phosphorylation of h1 calponin, 10-9 mol/L epsilon-
V1-2 (PKC-ε specific inhibitor, Anaspec, American) was
administered to the tissue baths after adding 10-9 mol/L
Psi-RACK(PKC-ε activator) and not adding Psi-RACK
groups. At the end of experiments, muscle strips were
snapping frozen in liquid N2 for Western Blot Analysis.
Statistical analysis
Data were presented as mean ± standard deviation (SD).
Statistical significance was determined by one-way
ANOVA using the SPSS 13.0 statistics package. Statis-
tical significance was set at P< 0.05.
Results
The expression and phosphorylation of h1 calponin were
increased during pregnancy and labor
We explored the expression level of h1 calponin and
phospho-h1 calponin in the samples of myometriumstrips from nonpregnant mice or pregnant mice in dif-
ferent stages of pregnancy by the method of western blot
with h1 calponin and phospho- h1 calponin (p- h1 cal-
ponin) antibodies. The phospho-h1 calponin antibody is
specific for h1 calponin phosphorylated at a PKC phos-
phorylation site, Ser175. Band densities were quantitated
by using Gel Pro Analyzer 4 image analysis software.
The total h1 calponin protein levels were significantly
increased in mice myometrium during pregnancy, in
comparison with that in the strips from the nonpregnant
mice (Figure 1A, 1B). However, the phospho-h1 calponin
levels were significantly expressively increased in mice
myometrium from the 17th Day during pregnancy till
the labor in contrast with that in nonpregnant mice.
Nevertheless, the ratio of phosphorylated h1 calponin/
total h1 calponin was significantly increased in myome-
trium in the mice in labor as compared with that in
pregnant or nonpregnant mice (Figure 1C). There was
no significant difference in the ratio of phosphorylated
h1 calponin/total h1 calponin among the nonpregnant
mice and pregnant mice.
The expression and phosphorylation of PKC-ε were
increased during pregnancy and labor
We explored the expression level of PKC-ε and phos-
pho-PKC-ε in the samples of myometrium strips from
nonpregnant mice or pregnant mice in different stages
of pregnancy by the method of western blot with PKC-ε
and phospho-PKC-ε antibodies. Total PKC-ε protein
level was significantly increased in pregnant or labor
mice myometrium strips (Figure 2A, 2B) comparing
with that in nonpregnant mice myometrium strips.
The phospho-PKC-ε protein level got arising signifi-
cantly from the 18th Day during the pregnancy till
labor, contrasted with nonpregnant mice. But the ratio
of phosphorylated PKC-ε/total PKC-ε was increased
significantly in labor, which consistent with the time
course of the changes in h1 calponin phosphorylation
(Figure 2B, 2C).
The effect of PKC-ε activator and inhibitor on the
expression and phosphorylation of h1 calponin in the
mice myometrium strips
The increased h1 calponin phosphorylation seen at the
end of term could be due to many factors. To investi-
gate whether PKC-ε directly regulates h1 calponin
phosphorylation, we exposed mice myometrial strips
in vitro to PKC-ε specific activator (Psi-RACK) [19].
Myometrial strips from late-pregnant (day 19, D19)
mice were stimulated with the Psi-RACK after the
spontaneous contraction of the strips had become
stable. The concentration of Psi-RACK ranged from
10-12 mol/L to 10-6 mol/L. The changes of myome-
trium strips contractility was quantitated by integrating
Figure 1 The expression of h1 calponin and phosphorylated h1 calponin during different stages of pregnancy in mice. Figure legend
text Total protein extracted from the smooth muscle layer of mouse uterus was analyzed on SDS-PAGE and transferred to nitrocellulose
membrane for western blotting with the anti-h1 calponin and anti-phosphorylated h1 calponin antibody. A: blots show the expression of h1
calponin and phosphorylated h1 calponin in the myometrium in different stages of pregnancy. B: columns from densitometry quantification of
multiple western blots(means ± SD; n = 10) summarize the changes in the expression of h1 calponin and phosphorylated h1 calponin. C: curves
from the ratio of phosphorylated h1 calponin to total h1 calponin. NP: non-pregnant; D7: Day 7 in pregnancy; D12: Day 12 in pregnancy; D17:
Day 17 in pregnancy; D18: Day 18 in pregnancy; D19: Day 19 in pregnancy; IL: in labor; h1 Cap: h1 calponin; p- h1 Cap: phosphorylated h1
calponin .*: P< 0.05, compared with NP; **: P< 0.01, compared with NP; Δ: P< 0.05, compared with NP; ΔΔ: P< 0.01, compared with NP. Results
demonstrated that total h1 calponin expression level gradually increased as the pregnancy progression, reached the peak before labor and
continued until labor; the phosphorylation of h1 calponin expression levels increased gradually with the progress of pregnancy, reached the peak
after labor. The ratio of phosphorylated h1 calponin to the total h1 calponin had no significant changes during pregnancy, but reached a peak
after the onset of labor.
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with control group without Psi-RACK, treatment with
Psi-RACK in organ bath solution induced myometrium
contraction in a dose-dependent manner (Figure 3A,
3B). The amplitude of myometrium strips contraction
exposed to more than 10-9 mol/L Psi-RACK was sig-
nificantly higher than that in control strips. To con-
firm that the contractile response was indeed due to
PKC-ε activity, strips activated by 10-9 mol/L Psi-
RACK and without were both treated with 10-9 mol/L
epsilon-V1-2(PKC-ε specific inhibitor). Strips in Krebs
solution without drugs acted as the sham-control. Theresults showed epsilon-V1-2 could reduce the ampli-
tude of contraction of activated strips by Psi-RACK,
but could not significantly reduce the contraction of
strips which wasn't activated. We detected the expres-
sion level of h1 calponin and phospho-h1 calponin in
myometrium strips with the method of western blot.
We found that the ratio of phospho-h1 calponin to
total h1 calponin got significantly increased in the
strips exposed to 10-9 mol/L Psi-RACK as compared
with control, but no difference among control groups,
epsilon-V1-2 groups and Psi-RACK + epsilon-V1-2
groups. (Figure 3C, 3D).
Figure 2 The expression of PKC-ε and phosphorylated PKC-ε during different stages of pregnancy in mice. Total protein extracts from
the smooth muscle layer of mouse uterus was analyzed on SDS-PAGE and transferred to nitrocellulose membrane for western blotting with the
anti-PKC-ε and anti-phosphorylated PKC-ε antibody. A: blots show the expression of PKC-ε and phosphorylated PKC-ε in the myometrium in
different stages of pregnancy. B: columns from densitometry quantification of multiple western blots (means ± SD; n = 10) summarize the
changes in the expression of PKC-ε and phosphorylated PKC-ε. C: curves from the ratio of phosphorylated PKC-ε to total PKC-ε. NP: non-pregnant;
D7: Day 7 in pregnancy; D12: Day 12 in pregnancy; D17: Day 17 in pregnancy; D18: Day 18 in pregnancy; D19: Day 19 in pregnancy; IL: in labor.
*: P< 0.05, compared with NP; **: P< 0.01, compared with NP; Δ: P< 0.05, compared with NP; ΔΔ: P< 0.01, compared with NP. Results
demonstrated that total PKC-ε expression level gradually increased as the pregnancy progression, reached the peak before labor and continued until
labor; the phosphorylation of PKC-ε expression levels increased gradually with the progress of pregnancy, reached the peak after labor. The ratio of
phosphorylated PKC-ε to the total PKC-ε had no significant changes during pregnancy, but reached a peak after the onset of labor.
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As in all muscle tissue, the predominant proteins
expressed in uterine smooth muscle are myosin and
actin. In uterine smooth muscle, there is ~6-fold more
actin than myosin [20]. Thin filaments (6-8 nm dia-
meters) are polymers of globular monomeric actin.
Thick filaments (15-18 nm diameters) are made up of
myosin. In general, the actin and myosin filaments run
in parallel and in the longitudinal dimension of the cell.
All contractility is initiated by changes in the activity of,
or interactions of, actin and myosin. In recent years,
multitudes of signaling pathways have been suggested toregulate smooth muscle contractility; however, mechan-
isms that regulate the availability of actin to interact with
myosin via the action of inhibitory actin binding proteins
such as caldesmon (CaD) and possibly calponin (CaP)
are strongly implicated in preterm labor[2]. During preg-
nancy, myometrial smooth muscle undergo profound
and large changes, including disruption of the myofila-
ments or cytoskeleton. It is necessary to recover greater
amounts of thin filament-associated proteins from non-
pregnant tissues. Calponin may be expressed at levels
reaching stoichiometric equivalence with actin, and has
been proposed to be a load-bearing protein. H1 calponin
Figure 3 The effect of PKC-ε specific activator (PSI-RACK) and inhibitor on the contraction of the mice myometrium strips at the day
19 during pregnant. A: typical recording of the contraction amplitude of myometrium strips was exposed to different dosage of PKC-ε specific
activator (Psi-RACK) in the organ bath experiments. B: mean values of AUC (area of under a curve) were recorded in myometrium strips opposed
to different dosage of PKC-ε specific activator (Psi-RACK) in the organ bath experiments. C: blots show the expression of calponin and h1-calponin
in the myometrium strips opposed to PKC-ε activator or inhibitor. D: columns from the ratio of phosphorylated h1 calponin to total h1 calponin in the
myometrium strips opposed to PKC-ε activator or inhibitor. (0: control, I: Psi-RACK (PKC-ε activator) 10-9 mol/L, II: epsilon-V1-2(PKC-ε inhibitor) 10-9
mol/L, III: Psi-RACK 10-9 mol/L + epsilon-V1-2 10-9 mol/L). h1 Cap: h1 calponin; p- h1 Cap: phosphorylated h1 calponin. *: P< 0.05, compared with
control.
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the formation of cytoskeleton [21].
We have observed the protein expression of h1 calpo-
nin in the uterine of mice, which was detected with the
method of Western Blot during different trimester of
pregnancy. Here we demonstrated that h1 calponin pro-
tein level significantly increased in mice myometrium in
late pregnancy and during labor compared with non-
pregnant controls. The gain of h1 calponin may contrib-
ute to recover the cytoskeleton in the pregnant
myometrium. The difference of the protein expression of
h1 calponin not only demonstrated that the expressionof h1 calponin was associated with the physiological
state of mice but also suggested that the alternation of
the h1 calponin during pregnancy laid the groundwork
for regulating the contraction of mice uterine.
Reversible phosphorylation of proteins is an important
regulatory mechanism that occurs in both prokaryotic
and eukaryotic organisms. Many enzymes and receptors
are switched "on" or "off" by phosphorylation and
dephosphorylation. Protein phosphorylation is an omni-
present and important dynamic phenomenon in living
systems that affects protein structure, protein-protein
interactions and catalytic activity during physiological
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this study is specific for h1 calponin phosphorylated at a
PKC phosphorylation site, Ser175. PKC is a family in-
cluding conventional isoforms(α, β, and γ), novel iso-
forms (δ, ε, η, and θ), atypical isoforms (i/λ and ξ) and
PKD/μ [22]. Some studies indicate h1 calponin is the
possible target of PKC-ε, and PKC-ε can interact with h1
calponin through the C-terminal repeats [13]. The PKC-
ε is widely expressed throughout the body and has im-
portant roles in the function of the nervous [23], cardiac
[24] and immune [25] systems. It is an attractive drug
target for the treatment of several conditions such as in-
flammation [25], ischemia [26], addiction [27], pain [28],
anxiety [29], and cancer [30]. Therefore, there is interest
in discovering additional drug targets through identifica-
tion of PKC-ε substrates and the signal pathways in
which they participate.
In our experiments, it was been found that PKC-ε
was activated with the use of its specific antibody in
the western blot in labor, at the same time an increase
in phosphorylation of h1 calponin at the Ser175 site
was observed. The outcomes suggested that h1 calponin
and its phosphorylation were helpful to or associated
with labor. Meanwhile, we have designed the following
organ bath experiments with the purpose of promoting
the contraction of uterine myometrium at the time of
Day 19 in pregnancy: 1. Muscle tension was recorded
with isometric force transducers connected to a com-
puter-controlled Gemini recorder (Chengdu Instru-
ments, China) after the application of different dose of
the activator of PKC-ε and of inhibitor of PKC-ε. 2.
The levels of h1 calponin and phospho-h1 calponin
were detected with the method of western blot spon-
taneously. The experimental results showed that the
mean amplitude of the myometrium contractions and
the ratio of phospho-h1 calponin/h1 calponin repre-
senting the degree of phosphorylation of the h1 calpo-
nin in the myometrial strips of mice were increased by
exposing myometrial strips to Psi-RACK (the PKC-ε
specific activator) more than 10-9 mol/L Psi-RACK, a
PKC-ε specific activator, which can activate the PKC-ε
to phosphorylated h1 calponin. Still, a positive correl-
ation was found between the amplitude of the myome-
trium strips and the degree of h1 calponin
phosphorylation. All these findings gave us suggestion
that contractions of myometrium strips in labor mice
were promoted by phospho-h1 calponin. Furthermore,
another step was established to verify the effect of
PKC-ε on the h1 Calponin: contractions of day 19 preg-
nant mice myometrium were recorded after adding
some inhibitor of PKC-ε(epsilon-V1-2) followed by add-
ing the PKC-ε activator(10-9 mol/L Psi-RACK) into the
medium of organ bath. We found that epsilon-V1-2
could decrease the level of phospho-h1 calponin onstips activated by Psi-RACK, but had no significant ef-
fect on the contraction of non-activated strips. Epsilon-
V1-2 is a 14- to 21-peptide sequence derived from the
first variable region V1 of the regulatory domain of
PKC-ε [31,32]. Its inhibitory activity is based on PKC-ε
translocation and PKC-ε phosphorylation[33]. We con-
jectured that PKC-ε translocation and phosphorylation
were not significantly happened in the strips without
adding Psi-RACK. So epsilon-V1-2 had no significantly
effect on the contraction of non-activated strips. The
result of this step could imply that the phosphorylation
of h1 Calponin was caused by the PKC-ε.
In vascular smooth muscle, through a PKC-ε-mediated
h1 calponin phosphorylation, h1 calponin becomes dis-
associated from acto-myosin, allowing for cross-bridg-
ing, thus initiating smooth muscle contraction [12]. All
findings in our studies strongly implicated PKC-ε-
dependent h1 calponin phosphorylation have been
linked to uterine smooth muscle contraction. Thus we
postulate that PKC-ε-dependent h1 calponin phosphor-
ylation may reverse the inhibition of actomyosin interac-
tions by h1 calponin and may contribute to an increased
uterine contractility during labor.
Conclusions
In conclusion, we demonstrated that the PKC-ε activa-
tion, phosphorylation of h1 calponin at a PKC site
reached the peak in myometrium in the mice in labor.
Under the stimulation of the PKC-ε specific activator,
the contractility of myometrium strips from pregnant
mice was reinforced and the level of phosphorylated h1
calponin increased at the same time, which could be
interrupted by the specific inhibitor of PKC-ε. These
results constitute evidence for a role of the PKC-ε/h1
calponin pathway in the regulation of myometrial con-
tractility and development of parturition.
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